Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Patrono

Showing results (51-60 of 258) with videos related to

Pageof 26
Sort By:
European Heart Journal|January 25, 2022
Give genotype-guided dual antiplatelet therapy a second CHANCEGiovanna Liuzzo, Carlo Patrono
European Heart Journal|October 25, 2024
Weekly Journal Scan: the rise and OCEANIC fall of asundexian in atrial fibrillationGiovanna Liuzzo, Carlo Patrono
European Heart Journal|February 18, 2026
Weekly Journal Scan: Assessing the role of revascularization in patients with asymptomatic carotid artery stenosisRocco Vergallo, Carlo Patrono
European Heart Journal|March 25, 2026
Weekly Journal Scan: Tirzepatide did not SURPASS the cardiovascular benefits of dulaglutide in type 2 diabetesGiovanna Liuzzo, Carlo Patrono
European Heart Journal|December 10, 2024
Weekly Journal Scan: An EPIC comparison of edoxaban vs. dual antithrombotic therapy in atrial fibrillation and stable coronary artery diseaseGiovanna Liuzzo, Carlo Patrono
European Heart Journal|December 28, 2020
The REDUCE-IT verdict on eicosapentaenoic acid and cardiovascular outcome challenged with STRENGTHMassimo Volpe, Carlo Patrono
European Heart Journal|July 15, 2023
Heart failure and socioeconomic status: global differences and inequalitiesRocco Vergallo, Carlo Patrono
European Heart Journal|January 11, 2021
Aldosterone receptor antagonism in patients with diabetes and chronic kidney disease: new promises and old problemsCarlo Patrono, Massimo Volpe
European Heart Journal|February 16, 2024
Weekly journal scan: SURMOUNTing body weight regain with tirzepatide after successful lifestyle interventionGiovanna Liuzzo, Carlo Patrono
Journal of the American College of Cardiology|July 14, 2022
Less Thromboxane, Longer LifeCarlo Patrono, Bianca Rocca
Pageof 26

Showing results (51-60 of 258) with videos related to

Sort By:
Pageof 26
European Heart Journal|January 25, 2022
Give genotype-guided dual antiplatelet therapy a second CHANCEGiovanna Liuzzo, Carlo Patrono
European Heart Journal|October 25, 2024
Weekly Journal Scan: the rise and OCEANIC fall of asundexian in atrial fibrillationGiovanna Liuzzo, Carlo Patrono
European Heart Journal|February 18, 2026
Weekly Journal Scan: Assessing the role of revascularization in patients with asymptomatic carotid artery stenosisRocco Vergallo, Carlo Patrono
European Heart Journal|March 25, 2026
Weekly Journal Scan: Tirzepatide did not SURPASS the cardiovascular benefits of dulaglutide in type 2 diabetesGiovanna Liuzzo, Carlo Patrono
European Heart Journal|December 10, 2024
Weekly Journal Scan: An EPIC comparison of edoxaban vs. dual antithrombotic therapy in atrial fibrillation and stable coronary artery diseaseGiovanna Liuzzo, Carlo Patrono
European Heart Journal|December 28, 2020
The REDUCE-IT verdict on eicosapentaenoic acid and cardiovascular outcome challenged with STRENGTHMassimo Volpe, Carlo Patrono
European Heart Journal|July 15, 2023
Heart failure and socioeconomic status: global differences and inequalitiesRocco Vergallo, Carlo Patrono
European Heart Journal|January 11, 2021
Aldosterone receptor antagonism in patients with diabetes and chronic kidney disease: new promises and old problemsCarlo Patrono, Massimo Volpe
European Heart Journal|February 16, 2024
Weekly journal scan: SURMOUNTing body weight regain with tirzepatide after successful lifestyle interventionGiovanna Liuzzo, Carlo Patrono
Journal of the American College of Cardiology|July 14, 2022
Less Thromboxane, Longer LifeCarlo Patrono, Bianca Rocca
Pageof 26